Yong Zang

Also affiliated with Ministry of Education of the People's Republic of China, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis, Tianjin Medical University

MathematicsBiochemistry, Genetics and Molecular BiologyDecision SciencesMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.439Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

PancanQTLv2.0: a comprehensive resource for expression quantitative trait loci across human cancers

Nucleic Acids Research(2023)10.1093/nar/gkad916

Top 43%

0.439DataRank

Top 43%9 citations

Yuan Liu, Mei Luo, Jingwen Yang, Yamei Chen, Runhao Wang +5 more

Papers

Driven by 34 papers — median percentile 29. Top paper: “Preoperative stereotactic radiosurgery for patients with 1–4 brain metastases: A single-arm phase 2 trial outcome analysis (NCT03398694)”.

Preoperative stereotactic radiosurgery for patients with 1–4 brain metastases: A single-arm phase 2 trial outcome analysis (NCT03398694)

Neuro-Oncology Practice(2024)10.1093/nop/npae043

N/A

0.590DataRank · unranked

11 citations

Jack Shireman, Kevin Shiue, Aaron Kamer, LaKeisha Boyd, Yong Zang +15 more

Evaluating risk for alcohol use disorder: Polygenic risk scores and family history

Alcoholism Clinical and Experimental Research(2022)10.1111/acer.14772

N/A

0.553DataRank · unranked

39 citations

Emma C. Johnson, Sarah M. C. Colbert, Gayathri Pandey, Grace Chan, Lance O. Bauer +20 more

Polygenic contributions to alcohol use and alcohol use disorders across population-based and clinically ascertained samples

Psychological Medicine(2020)10.1017/s0033291719004045

N/A

0.546DataRank · unranked

37 citations

Sandra Sanchez-Roige, Laura Ación, Mark J. Adams, Kathleen K. Bucholz, Grace Chan +28 more

High Polygenic Risk Scores Are Associated With Early Age of Onset of Alcohol Use Disorder in Adolescents and Young Adults at Risk

Biological Psychiatry Global Open Science(2021)10.1016/j.bpsgos.2021.10.007

N/A

0.449DataRank · unranked

19 citations

Yumin Wang, Yong Zang, Dongbing Lai, Leah Wetherill, Howard J. Edenberg +46 more

A graph neural network model to estimate cell-wise metabolic flux using single cell RNA-seq data

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.23.310656

N/A

0.442DataRank · unranked

18 citations

Wennan Chang, Pengtao Dang, Xiaoyu Lu, Changlin Wan, Silpa Gampala +8 more

PancanQTLv2.0: a comprehensive resource for expression quantitative trait loci across human cancers

Nucleic Acids Research(2023)10.1093/nar/gkad916

Top 43%

0.439DataRank

Top 43%9 citations

Yuan Liu, Mei Luo, Jingwen Yang, Yamei Chen, Runhao Wang +5 more

The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trial

The Pharmacogenomics Journal(2023)10.1038/s41397-023-00315-w

N/A

0.416DataRank · unranked

15 citations

Marc B. Rosenman, Pengyue Zhang, Cathy R. Fulton, John T. Callaghan, Ann Holmes +16 more

TopDIA: A Software Tool for Top-Down Data-Independent Acquisition Proteomics

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.05.588302

N/A

0.287DataRank · unranked

4 citations

Xingzhao Xiong, Tian Xu, Yong Zang, Liangliang Sun, Xiaowen Liu +1 more

A generalized phase 1-2-3 design integrating dose optimization with confirmatory treatment comparison

Biometrics(2024)10.1093/biomtc/ujad022

N/A

0.241DataRank · unranked

4 citations

Peter F. Thall, Ying Yuan, Yong Zang

Characterization of proteoform post-translational modifications by top-down and bottom-up mass spectrometry in conjunction with UniProt annotations

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.04.535618

N/A

0.241DataRank · unranked

4 citations

Zhengming Ding, Yong Zang, Xiaowen Liu, Wenrong Chen

scFLUX: a web server for metabolic flux and variation prediction using transcriptomics data

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.18.496660

N/A

0DataRank · unranked

2 citations

Wennan Chang, Norah Alghamdi, Mengyuan Fei, Changlin Wan, Alex Lu +7 more

Generalized phase I‐II designs to increase long term therapeutic success rate

Pharmaceutical Statistics(2023)10.1002/pst.2301

N/A

0DataRank · unranked

12 citations

Yong Zang, Ying Yuan, Peter F. Thall

Modified isotonic regression based phase I/II clinical trial design identifying optimal biological dose

Contemporary Clinical Trials(2023)10.1016/j.cct.2023.107139

N/A

0DataRank · unranked

8 citations

Yi Zhao, Hao Liu, Sha Cao, Chi Zhang, Yong Zang +1 more

Novel Clinical Trial Designs with Dose Optimization to Improve Long-term Outcomes

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2222

N/A

0DataRank · unranked

8 citations

Yong Zang, Andrew Chapple, Ying Yuan, Ruitao Lin, David Marín +2 more

Adaptive phase I–II clinical trial designs identifying optimal biological doses for targeted agents and immunotherapies

Clinical Trials(2024)10.1177/17407745231220661

N/A

0DataRank · unranked

16 citations

Beibei Guo, Yingjie Qiu, Hao Liu, Mateusz Opyrchal, Xiongbin Lu +1 more

Ancestral Differences in Anticancer Treatment Efficacy and Their Underlying Genomic and Molecular Alterations

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0827

N/A

0DataRank · unranked

10 citations

Jingwen Yang, Alejandro A. Schäffer, Chengxuan Chen, Yuan Liu, Yamei Chen +9 more

TopDIA: A Software Tool for Top-Down Data-Independent Acquisition Proteomics

Journal of Proteome Research(2024)10.1021/acs.jproteome.4c00293

N/A

0DataRank · unranked

6 citations

Xingzhao Xiong, Tian Xu, Yong Zang, Liangliang Sun, Xiaowen Liu +1 more

T3 + 3: 3 + 3 Design With Delayed Outcomes

Pharmaceutical Statistics(2024)10.1002/pst.2414

N/A

0DataRank · unranked

2 citations

Mengyi Lu, Isabella Wan, Yu‐Min Wang, Leng Han, Yong Zang +1 more

CDHu40: a novel marker gene set of neuroendocrine prostate cancer (NEPC)

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.28.587205

N/A

0DataRank · unranked

0 citations

Hye Seung Nam, Ziyu Zeng, Xuehong Deng, Elnaz Pashaei, Yong Zang +8 more

DiCE: differential centrality-ensemble analysis based on gene expression profiles and protein–protein interaction network

Nucleic Acids Research(2025)10.1093/nar/gkaf609

N/A

0DataRank · unranked

9 citations

Sheng Liu, Kailing Li, Yong Zang, Lei Yang, Tim Lautenschlaeger +4 more

STK11 coordinates IL-4 signaling with metabolic reprogramming to control M2 macrophage polarization and antitumor immunity

Science Advances(2025)10.1126/sciadv.adx5495

N/A

0DataRank · unranked

4 citations

Naresh Singh, Chengxian Xu, Dehui Kong, Samantha Sharma, Sheng Liu +15 more

Precision generalized phase I-II designs

Biometrics(2025)10.1093/biomtc/ujaf043

N/A

0DataRank · unranked

0 citations

Peter F. Thall, Ying Yuan, Juhee Lee, Pavlos Msaouel, Yong Zang +1 more

DrugCombo: an informatics bridge for anticancer drug combination Phase I trial design

Database(2025)10.1093/database/baaf043

Top 100%

0DataRank

Top 100%0 citations

Shijun Zhang, Lai Wei, Yuxi Zhu, Naleef Fareed, Lijun Cheng +8 more

Enrollment of Diverse Populations in the INGENIOUS Pharmacogenetics Clinical Trial

Frontiers in Genetics(2020)10.3389/fgene.2020.00571

N/A

0DataRank · unranked

8 citations

Kenneth D. Levy, Yong Zang, Ann Holmes, Christa L. Stoughton, Paul Dexter +2 more

Great Wall: A Generalized Dose Optimization Design for Drug Combination Trials Maximizing Survival Benefit

Pharmaceutical Statistics(2025)10.1002/pst.70049

N/A

0DataRank · unranked

0 citations

Yingjie Qiu, Yi Zhao, Isabella Wan, Lang Li, Suyu Liu +2 more

TSNP: A two‐stage nonparametric phase I/II clinical trial design for immunotherapy

Pharmaceutical Statistics(2020)10.1002/pst.2075

N/A

0DataRank · unranked

8 citations

Hao Liu, Sha Cao, Chi Zhang, Yong Zang, Yan Han

Using a developmental perspective to examine the moderating effects of marriage on heavy episodic drinking in a young adult sample enriched for risk

Development and Psychopathology(2020)10.1017/s0954579420000371

N/A

0DataRank · unranked

5 citations

Rebecca L. Smith, Kathleen K. Bucholz, Grace Chan, Howard J. Edenberg, Victor Hesselbrock +8 more

Pilot study of fetal brain development and morphometry in prenatal opioid exposure and smoking on fetal MRI

Journal of Neuroradiology(2021)10.1016/j.neurad.2020.12.004

N/A

0DataRank · unranked

23 citations

Brandon P. Brown, David M. Haas, Yong Zang, Christina Sparks, Senthilkumar Sadhasivam +1 more

BIPSE: A biomarker‐based phase I/II design for immunotherapy trials with progression‐free survival endpoint

Statistics in Medicine(2021)10.1002/sim.9265

N/A

0DataRank · unranked

9 citations

Yong Zang, Beibei Guo

CMAX3: A Robust Statistical Test for Genetic Association Accounting for Covariates

Genes(2021)10.3390/genes12111723

N/A

0DataRank · unranked

5 citations

Yong Zang, Zhongxue Chen

A graph neural network model to estimate cell-wise metabolic flux using single-cell RNA-seq data

Genome Research(2021)10.1101/gr.271205.120

N/A

0DataRank · unranked

237 citations

Wennan Chang, Pengtao Dang, Xiaoyu Lu, Changlin Wan, Silpa Gampala +8 more

Evaluation of machine learning models for proteoform retention and migration time prediction in top-down mass spectrometry

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.31.466700

N/A

0DataRank · unranked

2 citations

Elijah N. McCool, Liangliang Sun, Yong Zang, Xia Ning, Xiaowen Liu +1 more

A Bayesian phase I/II design to determine subgroup‐specific optimal dose for immunotherapy sequentially combined with radiotherapy

Pharmaceutical Statistics(2022)10.1002/pst.2265

N/A

0DataRank · unranked

6 citations

Yong Zang, Li‐Hsiang Lin, Rui Zhang, Beibei Guo

TopFD - A Proteoform Feature Detection Tool for Top-Down Proteomics

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.11.511828

N/A

0DataRank · unranked

9 citations

Yong Zang, Liangliang Sun, Xiaowen Liu, Abdul Rehman Basharat

Yong Zang

Indexed papers

Top data-sharing exemplar

Papers